Patent · US Active

Antigene oligomers inhibit transcription

US8999943B2 · kind B2 · utility

0Cited by
5References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 14, 2006
Grant dateApr 7, 2015
Priority date
Expiry dateJan 11, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/30
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Transcription of a gene in a mammalian cell is methylase-independently inhibited by contacting the cell with a nucleic acid oligomer of 12-28 bases complementary for a partially single-stranded target genomic sequence of the gene.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.